Skip to content

Drug interactions

Linagliptin + Stiripentol

Severity: Minor

Linagliptin and Stiripentol: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Stiripentol inhibits and induces CYP3A4 and inhibits P-gp, so linagliptin exposure could shift in either direction. Linagliptin is mostly eliminated unchanged, so significant changes are unlikely.

What this interaction means in plain words

Linagliptin and Stiripentol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Linagliptin belongs to Endocrine; Stiripentol belongs to Central Nervous System.

Evidence level: Low

Why it happens

Mixed CYP3A4 inhibition/induction and P-gp inhibition by stiripentol may alter linagliptin disposition.

What to do

No empiric adjustment; monitor glycemic control and adverse effects when stiripentol is started or stopped.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Linagliptin and Stiripentol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Linagliptin with Stiripentol?

MediHelp rates the interaction as minor. Linagliptin and Stiripentol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Stiripentol inhibits and induces CYP3A4 and inhibits P-gp, so linagliptin exposure could shift in either direction. Linagliptin is mostly eliminated unchanged, so significant changes are unlikely.

How serious is the interaction between Linagliptin and Stiripentol?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empiric adjustment; monitor glycemic control and adverse effects when stiripentol is started or stopped.

What other medicines interact with Linagliptin?

MediHelp also lists interactions of Linagliptin with, for example, Alogliptin-pioglitazone, Amlodipine-benazepril, Amobarbital. The full list is on the Linagliptin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in